FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

10570811000001106: Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
36039501000001112 Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
43177401000001116 Viracept 625mg tablets (Imported (United States)) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction imported true Inferred relationship Existential restriction modifier
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) Is a Nelfinavir 625mg tablets true Inferred relationship Existential restriction modifier
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) Is a Nelfinavir 625mg tablets false Inferred relationship Existential restriction modifier
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) Is a Product containing precisely nelfinavir 625 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) Has active ingredient Nelfinavir false Inferred relationship Existential restriction modifier
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Nelfinavir true Inferred relationship Existential restriction modifier
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) Has specific active ingredient Nelfinavir mesilate true Inferred relationship Existential restriction modifier
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) Has basis of strength substance Nelfinavir true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet Is pack of False Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) Inferred relationship Existential restriction modifier
Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) 120 tablet Has AMP True Viracept 625mg tablets (Agouron Pharmaceuticals, Inc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start